Please provide your email address to receive an email when new articles are posted on . Samsca, also known as tolvaptan, was safe when combined with conventional diuretics and presented promising ...

BALDWIN PARK, CA / ACCESSWIRE / July 26, 2019 / Since 2015, Premier Pharmacy Services has been part of a pharmacy network, designed by Otsuka America Pharmaceutical, Inc. (Otsuka) to distribute SAMSCA ...

Otsuka and the FDA are notifying healthcare professionals of significant liver injury associated with the use of Samsca (tolvaptan) tablets. Samsca is a selective vasopressin V 2-receptor antagonist ...

The FDA has determined that Samsca (tolvaptan; Otsuka) tablets should not be used for longer than 30 days and should not be used in patients with underlying liver disease due to possible livery injury ...

Please provide your email address to receive an email when new articles are posted on . Blood urea nitrogen level and urinary sodium excretion correlated with response to Samsca, or tolvaptan, in ...

HealthDay News — The FDA is advising health care providers to monitor patients who take the hyponatremia drug tolvaptan (Samsca, Otsuka) for hepatic injury, after reports of significant liver injury ...

Camber is introducing tolvaptan tablets, the generic of Otsuka’s Samsca. [Read more: Camber wins HDA's DIANA Award] The medication is used to treat hyponatremia, low levels of sodium in your blood, in ...

The FDA has approved Samsca tablets (tolvaptan) to treat hyponatremia, one of the most common electrolyte disorders seen in hospitalized patients. Hypnoatremia is associated with heart failure, ...

The FDA has issued a drug safety communication concerning tolvaptan (Samsca, Otsuka), a selective vasopression V2-receptor antagonist used in heart failure patients to treat clinically significant ...

Otsuka’s Samsca has been approved in Japan as a treatment for a rare genetic form of kidney disease. Samsca (tolvaptan) is the first approved treatment anywhere in the world for autosomal dominant ...

Japan's Ministry of Health, Labour and Welfare (MHLW) has become the first regulator in the world to OK the use of Otsuka's Samsca (tolvaptan), making it the first approved treatment for the rare ...

you can get e-magazine links on WhatsApp. Click here Otsuka bags FDA nod for oral selective vasopressin antagonist Samsca ...